<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00565630</url>
  </required_header>
  <id_info>
    <org_study_id>Drops vs. spray administration</org_study_id>
    <secondary_id>TAMC 06-306</secondary_id>
    <nct_id>NCT00565630</nct_id>
  </id_info>
  <brief_title>Using Device Delivering Ophthalmic Solution in a Spray Form Instead of Eye Drops</brief_title>
  <official_title>Pilot Study on Bioavailability of Vigamox Administered as Drops vs. as Spray</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Advanced Ophthalmic Pharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Advanced Ophthalmic Pharma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to confirm that Vigamox reaches similar aqueous concentration
      when administered as the commercially available eye drops or as a spray delivered from a
      proprietary device.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients scheduled for elective cataract surgery, will be randomly allocated to receive
      Vigamox 4 times , 1 hour prior to surgery, either via the experimental device in a spray
      form, or via the regular, commercially available bottle.

      Aqueous sample will be collected and submitted to a masked laboratory for measuring Vigamox
      concentration.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Replaced with ongoing study
  </why_stopped>
  <start_date>January 2008</start_date>
  <completion_date type="Anticipated">March 2008</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Aqeous concentration of Vigamox</measure>
    <time_frame>one month</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vigamox via the experiemntal device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vigamox drops from the commercially available bottles</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vigamox delivered via the device in spray form</intervention_name>
    <description>Vigamox delivered 4 times, 1 hour prior to cataract surgery</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for elective cataract surgery

        Exclusion Criteria:

          -  Known allergy to quinolone compounds
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adi Michaeli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept of Ophthalmology, TAMC, Tel Aviv, Israel</affiliation>
  </overall_official>
  <removed_countries>
    <country>Israel</country>
  </removed_countries>
  <verification_date>November 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2007</study_first_submitted>
  <study_first_submitted_qc>November 29, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2007</study_first_posted>
  <last_update_submitted>February 24, 2009</last_update_submitted>
  <last_update_submitted_qc>February 24, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 25, 2009</last_update_posted>
  <responsible_party>
    <name_title>Principle Investigator: Dr. Adi Michaeli</name_title>
    <organization>Dept. of Ophthalmology, TAMC, Tel Aviv, Israel</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ophthalmic Solutions</mesh_term>
    <mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
    <mesh_term>Moxifloxacin</mesh_term>
    <mesh_term>Fluoroquinolones</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

